Skip to main content
Caplight Logo









Watchfrog

Watchfrog

Private
FranceHealthcare & Life Scienceshttps://watchfrog.fr

Last Round

VC Round

Mar 31, 2015

Total Funding Raised

$780,000

Company Overview

Watchfrog operates in Healthcare & Life Sciences and is based in France. Its latest recorded funding round was a VC Round in March 2015.

Watchfrog is a biotechnology company that develops innovative in vivo bioassays for detecting endocrine disruptors and pollutants in water, chemical, and cosmetic samples.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Environmental Monitoring, Compliance & Risk, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Watchfrog Comparables

Compare Watchfrog with similar companies based on industry and business-model similarity.

Watchfrog comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ZeClinics
79%
Toxys
78%
BioDetection Systems B.V.
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Watchfrog Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 31, 2015
Series AMay 26, 2008
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Watchfrog Investors

Notable investors and investment history

Watchfrog investors
InvestorRounds
Groupe ChevrillonVC Round
GenopoleSeries A
KaristaVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors grew 155% MoM, reaching 2.2K.

  • Apr 8, 2026

    Grew 17% QoQ from 18 to 21 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Watchfrog Filings

Explore SEC and related filing metadata, where available.

Watchfrog filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Watchfrog's valuation, stock price, and market status.

Is Watchfrog a public or private company?

Watchfrog is a private company.

What is the current stock price of Watchfrog?

Watchfrog is a private company, so its shares have no public market price. Caplight tracks Watchfrog's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Watchfrog worth (valuation)?

Valuation information for Watchfrog is not publicly available.

Can I buy Watchfrog stock?

Watchfrog shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Watchfrog's last funding round?

Watchfrog's most recent funding round was VC Round on March 31, 2015.

Who are the main investors in Watchfrog?

Key investors in Watchfrog include Groupe Chevrillon, Genopole, Karista.

Will Watchfrog IPO soon?

No public IPO plans have been announced for Watchfrog.

How can I track Watchfrog secondary market activity?

Caplight tracks bids, offers, and trades in Watchfrog's shares on secondary markets.

Firmographic Details

HeadquartersFrance
Employee Range13
Year Founded2005
Last FundingMar 31, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?